<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9502136</article-id>
    <article-id pub-id-type="pmid">33983414</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab356</article-id>
    <article-id pub-id-type="publisher-id">btab356</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CNVfilteR: an R/Bioconductor package to identify false positives produced by germline NGS CNV detection tools</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Moreno-Cabrera</surname>
          <given-names>José Marcos</given-names>
        </name>
        <aff><institution>Hereditary Cancer Group, Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), Campus Can Ruti</institution>, Badalona, 08916 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Hereditary Cancer Program, Joint Program on Hereditary Cancer, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat</institution>, 08908 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>del Valle</surname>
          <given-names>Jesús</given-names>
        </name>
        <aff><institution>Hereditary Cancer Program, Joint Program on Hereditary Cancer, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat</institution>, 08908 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Castellanos</surname>
          <given-names>Elisabeth</given-names>
        </name>
        <aff><institution>Hereditary Cancer Group, Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), Campus Can Ruti</institution>, Badalona, 08916 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Clinical Genomics Unit, Clinical Genetics Service, Northern Metropolitan Clinical Laboratory, Germans Trias i Pujol University Hospital (HUGTiP), Campus Can Ruti</institution>, Badalona, 08916 Barcelona, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Feliubadaló</surname>
          <given-names>Lidia</given-names>
        </name>
        <aff><institution>Hereditary Cancer Program, Joint Program on Hereditary Cancer, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat</institution>, 08908 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pineda</surname>
          <given-names>Marta</given-names>
        </name>
        <aff><institution>Hereditary Cancer Program, Joint Program on Hereditary Cancer, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat</institution>, 08908 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2895-9857</contrib-id>
        <name>
          <surname>Serra</surname>
          <given-names>Eduard</given-names>
        </name>
        <aff><institution>Hereditary Cancer Group, Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), Campus Can Ruti</institution>, Badalona, 08916 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Capellá</surname>
          <given-names>Gabriel</given-names>
        </name>
        <aff><institution>Hereditary Cancer Program, Joint Program on Hereditary Cancer, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat</institution>, 08908 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Lázaro</surname>
          <given-names>Conxi</given-names>
        </name>
        <xref rid="btab356-cor1" ref-type="corresp"/>
        <aff><institution>Hereditary Cancer Program, Joint Program on Hereditary Cancer, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat</institution>, 08908 Barcelona, <country country="ES">Spain</country></aff>
        <aff><institution>Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
        <!--clazaro@iconcologia.net-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8878-349X</contrib-id>
        <name>
          <surname>Gel</surname>
          <given-names>Bernat</given-names>
        </name>
        <xref rid="btab356-cor1" ref-type="corresp"/>
        <aff><institution>Hereditary Cancer Group, Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), Campus Can Ruti</institution>, Badalona, 08916 Barcelona, <country country="ES">Spain</country></aff>
        <!--bgel@igtp.cat-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Robinson</surname>
          <given-names>Peter</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btab356-cor1">To whom correspondence should be addressed. <email>clazaro@iconcologia.net</email> or <email>bgel@igtp.cat</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-05-13">
      <day>13</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>13</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <volume>37</volume>
    <issue>22</issue>
    <fpage>4227</fpage>
    <lpage>4229</lpage>
    <history>
      <date date-type="received">
        <day>09</day>
        <month>11</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>06</day>
        <month>3</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>11</day>
        <month>4</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>5</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>13</day>
        <month>6</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab356.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Germline copy-number variants (CNVs) are relevant mutations for multiple genetics fields, such as the study of hereditary diseases. However, available benchmarks show that all next-generation sequencing (NGS) CNV calling tools produce false positives. We developed CNVfilteR, an R package that uses the single-nucleotide variant calls usually obtained in germline NGS pipelines to identify those false positives. The package can detect both false deletions and false duplications. We evaluated CNVfilteR performance on callsets generated by 13 CNV calling tools on three whole-genome sequencing and 541 panel samples, showing a decrease of up to 44.8% in false positives and consistent F1-score increase. Using CNVfilteR to detect false-positive calls can improve the overall performance of existing CNV calling pipelines.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>CNVfilteR is released under Artistic-2.0 License. Source code and documentation are freely available at Bioconductor (<ext-link xlink:href="http://www.bioconductor.org/packages/CNVfilteR" ext-link-type="uri">http://www.bioconductor.org/packages/CNVfilteR</ext-link>).</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Carlos III Health Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004587</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Government of Catalonia</institution>
            <institution-id institution-id-type="DOI">10.13039/501100002809</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>CERCA</institution>
            <institution-id institution-id-type="DOI">10.13039/100015439</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>PI16/00563</award-id>
        <award-id>PI19/00553</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>CIBERONC</institution>
            <institution-id institution-id-type="DOI">10.13039/501100014139</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2017SGR1282</award-id>
        <award-id>2017SGR496</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Copy-number variants (CNVs) are a type of structural variant which has been a matter of interest in multiple genetic fields. In the research and diagnosis of hereditary diseases, where CNVs are relevant contributors (<xref rid="btab356-B17" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic>, 2019</xref>), the analysis of germline CNVs plays a key role. Recent improvements in next-generation sequencing (NGS) have resulted in the release of several tools for germline CNV detection on whole-genome sequencing (WGS), whole-exome sequencing and panel data (<xref rid="btab356-B9" ref-type="bibr">Mason-Suares <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btab356-B13" ref-type="bibr">Roca <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btab356-B18" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic>, 2013</xref>). Nevertheless, CNV detection in NGS is challenging due to aspects relative to the technology, such as short-read lengths or GC-content bias (<xref rid="btab356-B15" ref-type="bibr">Teo <italic toggle="yes">et al.</italic>, 2012</xref>).</p>
    <p>Available benchmarks show that all germline CNV calling tools produce false positives (<xref rid="btab356-B4" ref-type="bibr">Kim <italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btab356-B10" ref-type="bibr">Moreno-Cabrera <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btab356-B17" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic>, 2019</xref>), frequently reaching high false discovery rates (FDRs). These false-positive calls impact downstream analysis. In a clinical setting, where the use of an orthogonal method is necessary to validate a CNV, false-positive calls lead laboratories to make an important effort to validate them. A tool able to identify these false-positive calls could help in this regard.</p>
    <p>Most NGS CNV callers are based on one or more of these strategies: read-pair, split-read, read-depth and assembly based (<xref rid="btab356-B12" ref-type="bibr">Pirooznia <italic toggle="yes">et al.</italic>, 2015</xref>). However, information from single-nucleotide variants (SNVs), usually available in NGS pipelines, is rarely used in CNV detection strategies although SNV allele frequency can provide evidence to confirm or discard CNV calls.</p>
    <p>Here, we present CNVfilteR, an R/Bioconductor package that uses SNVs to identify false positives in the output of CNV calling tools.</p>
  </sec>
  <sec>
    <title>2 False-positive identification strategy</title>
    <p>CNVfilteR uses two different strategies to identify false-positives CNV calls in diploid genomes. Heterozygous deletions are loss-of-heterozygosity regions and cannot overlap with heterozygous SNVs, since only one allele remains. If a heterozygous SNV is detected within a deleted region, either the SNV or the deletion is a false positive (<xref rid="btab356-F1" ref-type="fig">Fig. 1a</xref>). To account for errors in SNV calling, a CNV deletion is identified as false positive if at least a percentage of the SNVs overlapping that CNV is heterozygous, 30% by default. On the other hand, CNV duplications are evaluated using a fuzzy-logic-inspired model which scores all heterozygous SNVs overlapping the CNV. If the duplication was a true-positive, the expected allele frequency of heterozygous SNVs would be either 33% or 66%, while it would be 50% if the duplication was a false positive (<xref rid="btab356-F1" ref-type="fig">Fig. 1b</xref>). Therefore, each SNV is scored with a value between −1 and 1 depending on how close the allele frequency is to the nearest expected allele frequency (<xref rid="btab356-F1" ref-type="fig">Fig. 1c</xref>). If the sum of the scores of all the SNVs in the CNV is greater than the duplication threshold value, the CNV duplication is identified as false positive. Further details of the scoring model can be found in Supplementary File S1.</p>
    <fig position="float" id="btab356-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>(<bold>A</bold>) CNV deletion example, adapted from CNVfilteR output. (<bold>B</bold>) CNV duplication example, adapted from CNVfilteR output. (<bold>C</bold>) Scoring model for CNV duplications, plotted by CNVfilteR. (<bold>D–F</bold>) F1-score differences before (light blue) and after (dark blue) removing the false-positive CNVs identified by CNVfilteR in the HuRef, AK1 and NA12878 WGS samples</p>
      </caption>
      <graphic xlink:href="btab356f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>3 Features</title>
    <sec>
      <title>3.1 Input formats</title>
      <p>VCF format is the most common output of SNV callers and its interpretation is challenging due to the flexibility provided by the format specification. CNVfilteR provides a function to interpret automatically VCFs produced by VarScan2, Strelka/Strelka2, freeBayes, HaplotypeCaller (GATK) and UnifiedGenotyper (GATK). Output from other tools can also be loaded if adequate parameters are provided.</p>
    </sec>
    <sec>
      <title>3.2 Visual output</title>
      <p>Results can be plotted and customized through plotting functions based on karyoploteR (<xref rid="btab356-B3" ref-type="bibr">Gel and Serra, 2017</xref>) and CopyNumberPlots (<ext-link xlink:href="https://github.com/bernatgel/CopyNumberPlots" ext-link-type="uri">https://github.com/bernatgel/CopyNumberPlots</ext-link>) packages (Supplementary Fig. S1).</p>
    </sec>
  </sec>
  <sec>
    <title>4 Performance evaluation</title>
    <p>CNVfilteR was evaluated on 3 WGS samples and 541 gene-panel samples. The default parameters were chosen based on their performance in a WGS sample (HuRef sample) and a gene-panel dataset (HiSeq-panel) (<xref rid="sup1" ref-type="supplementary-material">Supplementary File S1</xref>).</p>
    <sec>
      <title>4.1 Evaluation on WGS data</title>
      <p>We evaluated CNVfilteR performance on three reference WGS samples: the HuRef/Venter genome (<xref rid="btab356-B19" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic>, 2018</xref>), the AK1 genome (<xref rid="btab356-B14" ref-type="bibr">Seo <italic toggle="yes">et al.</italic>, 2016</xref>) and the NA12878 genome. The HuRef and AK1 samples were evaluated using a published reference CNV callset and the results of six CNV calling tools (Canvas, cn. MOPS, CNVnator, ERDS, Genome_STRiP, RDXplorer) (<xref rid="btab356-B16" ref-type="bibr">Trost <italic toggle="yes">et al.</italic>, 2018</xref>). For these two samples, we also ran an additional CNV calling tool, LUMPY (<xref rid="btab356-B7" ref-type="bibr">Layer <italic toggle="yes">et al.</italic>, 2014</xref>). On the other hand, we evaluated the NA12878 sample with a reference callset and the output of ten CNV calling tools (Canvas, cn. MOPS, CNVnator, RDXplorer, iCopyDAV, GROM-RD, Rsicnv, Control-FREEC, ReadDepth) from a previous work (<xref rid="btab356-B8" ref-type="bibr">MacDonald <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btab356-B11" ref-type="bibr">Parikh <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btab356-B17" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic>, 2019</xref>). For the three WGS samples, SNV calls were obtained using Strelka2 (<xref rid="btab356-B5" ref-type="bibr">Kim <italic toggle="yes">et al.</italic>, 2018</xref>). Further details are available in Supplementary File S1.</p>
      <p>CNVfilteR identified between 15.3% and 44.8% of the false positives and the FDR decreased for all tool-sample evaluations (up to 10.4%). Additionally, F1-score was improved in 19 out of the 24 tool-sample evaluations reaching up to 20.7% F1-score increase (<xref rid="btab356-F1" ref-type="fig">Fig. 1d–f</xref>). Sensitivity, however, decreased slightly: tool-sample evaluations had an absolute sensitivity decrease between 0.001 and 0.035. Metrics details are available in Supplementary File S2 and Figures S2–S7. Moreover, additional evaluations were performed to show CNVfilteR performance on different CNV size ranges, on different number of SNVs overlapping each CNV, and on different parameter values (Supplementary Figs S8–S25 and Files S5–S7).</p>
    </sec>
    <sec>
      <title>4.2 Evaluation on gene-panel data</title>
      <p>We also evaluated CNVfilteR performance on two gene-panel targeted datasets: one containing 411 samples from different Illumina HiSeq runs (HiSeq-panel dataset) and another with 130 samples from different Illumina MiSeq runs (MiSeq-panel dataset). All samples were captured with a 135-gene panel (<xref rid="btab356-B1" ref-type="bibr">Castellanos <italic toggle="yes">et al.</italic>, 2017</xref>). To evaluate CNVfilteR, previous MLPA results for a subset of genes were used as gold-standard, CNVs were called using DECoN (<xref rid="btab356-B2" ref-type="bibr">Fowler <italic toggle="yes">et al.</italic>, 2016</xref>), and SNVs were called using VarScan2 (<xref rid="btab356-B6" ref-type="bibr">Koboldt <italic toggle="yes">et al.</italic>, 2012</xref>) (Supplementary Files S1, S3 and S4).</p>
      <p>In the HiSeq-panel and MiSeq-panel datasets, CNVfilteR identified 15% of the false-positive calls (3 out of 20 false positives) and 12.5% of the false-positive calls (2 out of 16), respectively.</p>
      <p>On both datasets, no true CNV was misidentified as false positive (Supplementary File S1), so sensitivity did not change.</p>
    </sec>
    <sec>
      <title>4.3 Runtime</title>
      <p>Runtime was evaluated on a subset of 79 gene-panel samples and the HuRef WGS sample. The median runtime per sample was 0.85 s for the gene-panel samples and 3.53 min for the HuRef sample (<xref rid="sup1" ref-type="supplementary-material">Supplementary File S1</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>5 Conclusion</title>
    <p>We developed CNVfilteR, an R/Bioconductor package to identify false-positive calls generated by CNV calling tools from germline NGS data using SNVs’ allele frequency. CNVfilteR identified false-positive calls in all tested tools and datasets, from gene-panel to WGS, and F1-score was improved in most tool-sample combinations. CNVfilteR can be plugged in most existing CNV calling pipelines to improve calling performance at virtually no cost.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btab356_Supplementary_Data</label>
      <media xlink:href="btab356_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We thank all members of the Genetic Diagnostics Units at ICO and IGTP for their help.</p>
    <sec>
      <title>Funding</title>
      <p>This work has been supported by Carlos III Health Institute co-funded by FEDER—a way to build Europe; the Government of Catalonia and CERCA. Contract grant numbers: PI16/00563, PI19/00553, CIBERONC, 2017SGR1282 and 2017SGR496.</p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btab356-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Castellanos</surname><given-names>E.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape</article-title>. <source>Sci. Rep</source>., <volume>7</volume>, <fpage>39348</fpage>.<pub-id pub-id-type="pmid">28051113</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fowler</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN</article-title>. <source>Wellcome Open Res</source>., <volume>1</volume>, <fpage>20</fpage>.<pub-id pub-id-type="pmid">28459104</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gel</surname><given-names>B.</given-names></string-name>, <string-name><surname>Serra</surname><given-names>E.</given-names></string-name></person-group> (<year>2017</year>) <article-title>KaryoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data</article-title>. <source>Bioinformatics</source>, <volume>33</volume>, <fpage>3088</fpage>–<lpage>3090</lpage>.<pub-id pub-id-type="pmid">28575171</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>H.-Y.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data</article-title>. <source>Oncotarget</source>, <volume>8</volume>, <fpage>27277</fpage>–<lpage>27285</lpage>.<pub-id pub-id-type="pmid">28460482</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Strelka2: fast and accurate calling of germline and somatic variants</article-title>. <source>Nat. Methods</source>, <volume>15</volume>, <fpage>591</fpage>–<lpage>594</lpage>.<pub-id pub-id-type="pmid">30013048</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koboldt</surname><given-names>D.C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2012</year>) <article-title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article-title>. <source>Genome Res</source>., <volume>22</volume>, <fpage>568</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">22300766</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Layer</surname><given-names>R.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2014</year>) <article-title>LUMPY: a probabilistic framework for structural variant discovery</article-title>. <source>Genome Biol</source>., <volume>15</volume>, <fpage>R84</fpage>.<pub-id pub-id-type="pmid">24970577</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacDonald</surname><given-names>J.R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2014</year>) <article-title>The Database of Genomic Variants: a curated collection of structural variation in the human genome</article-title>. <source>Nucleic Acids Res</source>., <volume>42</volume>, <fpage>D986</fpage>–<lpage>D992</lpage>.<pub-id pub-id-type="pmid">24174537</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mason-Suares</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Detecting copy number variation via next generation technology</article-title>. <source>Curr. Genet. Med. Rep</source>., <volume>4</volume>, <fpage>74</fpage>–<lpage>85</lpage>.</mixed-citation>
    </ref>
    <ref id="btab356-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moreno-Cabrera</surname><given-names>J.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Evaluation of CNV detection tools for NGS panel data in genetic diagnostics</article-title>. <source>Eur. J. Hum. Genet,</source>  <volume>28</volume>, <fpage>1645</fpage>–<lpage>1655</lpage>.<pub-id pub-id-type="pmid">32561899</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parikh</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Svclassify: a method to establish benchmark structural variant calls</article-title>. <source>BMC Genomics</source>, <volume>17</volume>, <fpage>64</fpage>.<pub-id pub-id-type="pmid">26772178</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pirooznia</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>Whole-genome CNV analysis: advances in computational approaches</article-title>. <source>Front. Genet</source>., <volume>06</volume>, <fpage>138</fpage>.</mixed-citation>
    </ref>
    <ref id="btab356-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roca</surname><given-names>I.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Free-access copy-number variant detection tools for targeted next-generation sequencing data</article-title>. <source>Mutat. Res. Rev. Mutat. Res</source>., <volume>779</volume>, <fpage>114</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">31097148</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seo</surname><given-names>J.S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>De novo assembly and phasing of a Korean human genome</article-title>. <source>Nature</source>, <volume>538</volume>, <fpage>243</fpage>–<lpage>247</lpage>.<pub-id pub-id-type="pmid">27706134</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Teo</surname><given-names>S.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2012</year>) <article-title>Statistical challenges associated with detecting copy number variations with next-generation sequencing</article-title>. <source>Bioinformatics</source>, <volume>28</volume>, <fpage>2711</fpage>–<lpage>2718</lpage>.<pub-id pub-id-type="pmid">22942022</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trost</surname><given-names>B.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>A comprehensive workflow for read depth-based identification of copy-number variation from whole-genome sequence data</article-title>. <source>Am. J. Hum. Genet</source>., <volume>102</volume>, <fpage>142</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">29304372</pub-id></mixed-citation>
    </ref>
    <ref id="btab356-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>L.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Comprehensively benchmarking applications for detecting copy number variation</article-title>. <source>PLoS Comput. Biol</source>., <volume>15</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="btab356-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives</article-title>. <source>BMC Bioinformatics</source>, <volume>14</volume>, <fpage>S1</fpage>.</mixed-citation>
    </ref>
    <ref id="btab356-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>B.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Extensive and deep sequencing of the Venter/HuRef genome for developing and benchmarking genome analysis tools</article-title>. <source>Sci. Data</source>, <volume>5</volume>, <fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">30482902</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
